- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 0
- Grants since 2016
- 3 213
Grants received
2022–2024 · research · R21
Role of epidermis in regulating inflammatory skin manifestations of post-surgical lymphedema
Babak J Mehrara · Kettering University · funded by National Institutes of Health
2022–2025 · fellowship · F32
Understanding tumorigenesis and metastasis of pancreatic cancer through precision whole-body imaging of senescence with ImmunoPET
Edwin Charles Pratt · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Minimizing salivary gland and renal toxicity arising from PSMA-targeted alpha therapy
Nagavarakishore Pillarsetty · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Defining the role of histone H3K4 mono-methyltransferase dysfunction in urothelial carcinoma
Yu Chen · Kettering University · funded by National Institutes of Health
2022–2027 · cooperative agreement · U24
M-ISIC: A Multimodal Open-Source International Skin Imaging Collaboration Informatics Platform for Automated Skin Cancer Detection
Kivanc Kose · Kettering University · funded by National Institutes of Health
2022–2025 · research · R21
A telehealth intervention to improve initiation of mental health treatment among depressed older adults with cancer
Kelly Mcconnell · Kettering University · funded by National Institutes of Health
2022–2027 · cooperative agreement · U24
Coordinating center for the NCI small cell lung cancer research consortium
Lauren Averett Byers · Kettering University · funded by National Institutes of Health
2022–2024 · research · R01
Role of FBXO45 in Diffuse Large B Cell Lymphoma Pathogenesis
Kojo S. J. Elenitoba-Johnson · Kettering University · funded by National Institutes of Health
2022–2025 · research · R03
Pathway to Equity: Feasibility and Proof of Concept of Meaning-Centered Psychotherapy for Chinese Patients with Advanced Cancer
Florence Lui · Kettering University · funded by National Institutes of Health
2022–2025 · research · RF1
[18F]-PU-AD epichaperome PET imaging probe
Gabriela Chiosis · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Structural and functional principles underlying germline genome transmission
Scott Keeney · Kettering University · funded by National Institutes of Health
2022–2026 · research · R01
Genomic biomarkers for cutaneous T-cell Lymphoma
Megan S. Lim · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Phase II Study of ASTX727 in Patients with PRC2 loss Malignant Peripheral Nerve Sheath Tumor (MPNST)
Ping Chi · Kettering University · funded by U.S. Food and Drug Administration
2022–2024 · research · R21
Enhancing Health Cost Literacy and Financial Capability among Young Adult Cancer Survivors
Bridgette H Thom · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Defining the role of histone H3K4 mono-methyltransferase dysfunction in urothelial carcinoma
Yu Chen · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Essential roles for RNAi/hpRNAs to resolve intragenomic conflicts in the male germline
Eric C Lai · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Randomized Trial of Exercise Therapy on Markers of Progression in Localized Prostate Cancer:
Paul Christopher Boutros · Kettering University · funded by National Institutes of Health
2022–2024 · research · R21
Communicating the Gist of Prognosis: An intervention to improve prognostic understanding in advanced lymphoma
Kelly Mcconnell · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Prolidase Inhibitors as Therapeutic Agents for Acute Myeloid Leukemia
Daniel Bachovchin · Kettering University · funded by National Institutes of Health
2022–2027 · research · R37
Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancer
Semanti Mukherjee · Kettering University · funded by National Institutes of Health
2022–2026 · career development · K00
Investigating the Role of Cell Plasticity in Malignant Transformation
Andrea Christine Chaikovsky · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Molecular origins and impact of APOBEC3 mutagenesis in cancer
John Maciejowski · Kettering University · funded by National Institutes of Health
2022–2024 · research · R21
Scalable, quantitative, single-cell CRISPR screens
Thomas Maxwell Norman · Kettering University · funded by National Institutes of Health
2022–2025 · research · R01
International Study of Subsequent Colorectal Cancer Among Survivors of Childhood, Adolescent, and Young Adult Cancers (I-SCRY)
Tara Olive Henderson · Kettering University · funded by National Institutes of Health
2022–2027 · career development · K08
Determining the role and function of a high plasticity cell state in lung adenocarcinoma
Jason Earl Chan · Kettering University · funded by National Institutes of Health
2022–2026 · research · R01
Identifying senescence and immune biomarkers predictive of benefit to combined CDK4 and checkpoint blockade inhibition in patients with dedifferentiated liposarcoma
Sandra P D'Angelo · Kettering University · funded by U.S. Food and Drug Administration
2022–2027 · career development · K08
Role of Fc Receptors in the Therapeutic Activity of Antibodies Targeting the CD47-SIRP-alpha axis
Juan C Osorio · Kettering University · funded by National Institutes of Health
2022–2027 · research · R50
Developing therapeutic TCR mimic monoclonal antibodies for cancer
Tao Dao · Kettering University · funded by National Institutes of Health
2022–2025 · fellowship · F31
Understanding the divergent functions of mutant p53
Margaret Kennedy · Kettering University · funded by National Institutes of Health
2022–2024 · research · R03
Impact of germline mutations on the development of breast-implant associated anaplastic large cell lymphoma (BIA-ALCL) in women with textured breast implants
Paola Ghione · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Ferroptosis and Cancer Cell Signaling
Xuejun Jiang · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Group 2 Innate Lymphoid Cell Regulation of Pancreatic Cancer Immunity
Vinod P Balachandran · Kettering University · funded by National Institutes of Health
2022–2025 · research · R33
Systematic characterization of cancer variants using single-cell functional genomics
Scott W. Lowe · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Minimizing salivary gland and renal toxicity arising from PSMA-targeted alpha therapy
Nagavarakishore Pillarsetty · Kettering University · funded by National Institutes of Health
2022–2027 · research · R01
Prolidase Inhibitors as Therapeutic Agents for Acute Myeloid Leukemia
Daniel Bachovchin · Kettering University · funded by National Institutes of Health
2022–2027 · career development · K08
The role of B-cells in the anti-tumor immune response in triple negative breast cancer
Stephanie M Downs-Canner · Kettering University · funded by National Institutes of Health
2022–2027 · research · R35
Regulation of genome replication, recombination, and stress response
Xiaolan Zhao · Kettering University · funded by National Institutes of Health
2022–2025 · fellowship · F31
Understanding the divergent functions of mutant p53
Margaret Kennedy · Kettering University · funded by National Institutes of Health
2022–2024 · research · R21
Architectural regulation of cytotoxic synapse detachment
Morgan A Huse · Kettering University · funded by National Institutes of Health
2022–2027 · research · R37
Development of a Clinical CEST MR Fingerprinting Method for Treatment Response Assessment in Brain Metastases
Ouri Cohen · Kettering University · funded by National Institutes of Health